BG-A3004
N/A
Report date: 2026/03/28 20:00:32
Base Information
Drug NameBG-A3004
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeigene Guangzhou Biologics Manufacturing Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A